Validated Assay Methods
Download our free White Paper to see our June 2020 Validated Assay Methods.
FARMOVS is a client-focused, quality-driven clinical research organisation based in South Africa, offering the full scope of Phase I to III clinical trials, from feasibility and protocol development to final study report.
FARMOVS is a client-focused, quality-driven clinical research organisation based in South Africa, offering the full scope of Phase I to III clinical trials, from feasibility and protocol development to final study report.
The World Health Organisation (WHO) pre-qualified FARMOVS as a bioequivalence centre, and services are compliant with the International Conference on Harmonisation-Good Clinical Practice (ICH-GCP) and Organisation for Economic Co-operation and Development-Good Laboratory Practice (OECD-GLP) guidance.
Standard operating procedures originate from the latest regulatory requirements and guidelines, as amended from time to time.
FARMOVS’ competitive advantage is its wealth of bioequivalence and Phase I experience and expertise. Since 1974, the company successfully managed and conducted more than 3,200 clinical trials for clients across the globe, ranging from small biotech companies to some of the world’s largest pharmaceutical companies.
The submission of clinical study reports to global and local regulators led to successful inspections by the FDA (US), representatives of the EMA [including AEMPS (Spain), AGES (Austria) and BfArM (Germany)], MHRA (UK), South African Health Products Regulatory Agency (SAHPRA), PMDA (Japan), NMPA (China), and the World Health Organisation.
FARMOVS is proud to be the only phase I clinical research unit on the African continent, with on-site International Organisation of Standardisation (ISO):15189 accredited and good laboratory practice (GLP) certified bioanalytical laboratories.
The company’s 10,000m² world-class research centre features well-appointed participant consultation and admission facilities, pharmacies and cutting-edge laboratory facilities, all equipped with state-of-the-art medical equipment.
The clinical unit has a total bed count of 108 in five wards (with a capacity of 20 beds per ward), and eight en-suite rooms that provide the needed comfort and personal convenience for participants admitted to the clinic for more extended periods.
One of the infirmaries regularly converted into a manual clamp unit for diabetic research includes short and long-acting insulin analogues.
An on-site research pharmacy registered with the South African Pharmacy Council (SAPC) assists with the importation storage, dispensing, recollection, return and destruction of the medicinal products used during the execution of the clinical trial.
The service is also extended to external clinical research sites, acting as a centralised pharmacy depot.
GLP-certified bioanalytical laboratory-developed and validated almost 600 methods and applied these methods to support more than 3,000 pre-clinical and clinical trials.
FARMOVS offers several bioanalytical techniques, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS), high-performance liquid chromatography (HPLC), enzyme-linked immunosorbent assays (ELISA) and radio-immunoassays (RIA).
The laboratory analyses over 125,000 samples a year, with the majority imported from clinical research centres located elsewhere. For this reason, the laboratory has a team of International Air Transport Association (IATA) certified logistical coordinators, who ensure the handling of sample shipments complies with international regulations, obtaining pre-arrival clearance from customs, and ensuring sample integrity during shipment.
An on-site ISO15189 accredited clinical laboratory performs the haematology, serology, blood chemistry, urinalysis and drugs of abuse assessments during the screening phase for inclusion and exclusion of trial participants, and during the study and post-study evaluations.
The clinical laboratory is available for safety assessments 24/7 on-demand of the Principal Investigator, with results released within two to four hours.
IT infrastructure includes an on-site server room with an off-site back-up of data daily. Server room and critical instruments connect to automated diesel back-up power generation.
FARMOVS employs 150 full-time staff members. For each job role, predefined job description details the company expectations of every employee. Team members undergo a core training curriculum to ensure proper and regular training, allowing adequate and continuous competency assessments.
FARMOVS operates within a developing economy with first-world medical standards and has the unique opportunity to enrol treatment naïve patients from a diverse population of different ethnic groups. A database of a wide range of medical conditions is continuously updated to ensure that the data is current and accurate.
The company successfully conducts studies in cardiovascular, central nervous system, dermatology, gynaecology, gastrointestinal tract and infectious diseases fields, as well as metabolic and endocrine, oncology, paediatric, psychiatry and respiratory domains.
Download our free White Paper to see our June 2020 Validated Assay Methods.
FARMOVS is a leading Clinical Research Organisation (CRO) with a unique advantage. With the only on-site ISO accredited and GLP certified Bioanalytical Laboratory on the African continent they offer the highest quality bioanalytical services for qualitative and quantitative drug, metabolite, and biomarker analysis in a variety of matrices. With advanced technology and backed by 30 years of bioanalytical experience, they have developed more than 550 validated analytical methods that adhere to ICH and FDA guidelines. Their analytical methods have been used in more than 3,000 pre-clinical and clinical trials, contributing to the manufacturing of pharmaceutical drugs that are now used by most households.
13 August 2021The Bioanalytical Services Division (BASD) at FARMOVS comprises of a group of skilled and passionate scientists involved in the quantification of drugs, metabolites and biomarkers in various biological matrices. One of their Analytical Science experts, Fletcher Hiten, explains what sets their team apart from the rest.
28 June 2021Quite recently, multinational businesses realized that acclimating to the turbulence brought about by COVID-19, would not ensue as effortlessly as expected. However, those who invested in clinical research partners who have implemented the decentralised clinical trial (DCT) model prior to the pandemic, reaped extraordinary benefits.
12 May 2021Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology